| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
34,665 |
29,962 |
$3.43M |
| 88342 |
|
13,168 |
10,018 |
$1.30M |
| 88173 |
|
3,034 |
2,523 |
$336K |
| 88341 |
|
1,416 |
1,265 |
$192K |
| 88313 |
|
2,113 |
1,838 |
$168K |
| 88307 |
|
1,263 |
1,186 |
$167K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,240 |
3,080 |
$154K |
| 88304 |
|
4,244 |
3,879 |
$143K |
| 10005 |
|
1,691 |
1,559 |
$138K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,008 |
2,369 |
$114K |
| 88142 |
|
5,581 |
4,630 |
$112K |
| 88172 |
|
2,353 |
1,933 |
$112K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,173 |
3,022 |
$78K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,085 |
1,679 |
$61K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,090 |
1,681 |
$60K |
| 88177 |
|
1,885 |
1,563 |
$60K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
655 |
587 |
$32K |
| 10022 |
|
652 |
348 |
$28K |
| 88302 |
|
648 |
584 |
$24K |
| 88141 |
|
671 |
523 |
$14K |
| 99241 |
|
1,063 |
812 |
$13K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
546 |
400 |
$13K |
| 88312 |
|
134 |
122 |
$11K |
| 88108 |
|
197 |
126 |
$6K |
| 88311 |
|
163 |
157 |
$3K |
| 88360 |
|
16 |
12 |
$2K |
| 10006 |
|
46 |
41 |
$2K |
| 87590 |
|
62 |
53 |
$2K |
| 87490 |
|
62 |
53 |
$2K |
| 99201 |
|
69 |
68 |
$1K |
| 88112 |
|
12 |
12 |
$579.12 |